补中益气汤合二陈汤联合针刺对慢阻肺患者的临床观察  

Clinical Observation of Buzhongyiqi Decoction,Erchen decoction and Acupuncture in Chronic Obstructive Pulmonary Disease Patients

作　　者：王丹[1] 袁文佳 WANG Dan;YUAN Wenjia(Department of Respiratory Rehabilitation,Zhengzhou Central Hospital Rehabilitation Branch,Zhengzhou Henan 450007,China;Department of Traditional Chinese Medicine,Yellow River Central Hospital,Zhengzhou Henan 450007,China)

机构地区：[1]郑州市中心医院康复分院呼吸康复科,河南郑州450007 [2]黄河中心医院中医科,河南郑州450007

出　　处：《临床研究》2024年第4期88-91,共4页Clinical Research

摘　　要：目的分析补中益气汤合二陈汤加针刺对慢阻肺(COPD)患者的疗效。方法2019年8月至2022年8月郑州市中心医院康复分院收治COPD患者总共65例,经随机数字表法分成对照组(常规西医疗法)33例和观察组(在对照组基础上采取补中益气汤合二陈汤加针刺疗法)32例,比较两组疗效、症状评分;治疗前后咳嗽、喘息、咳痰和肺呼吸音症状评分;血氧分压(PaO_(2))及二氧化碳分压(PaCO_(2))血气分析指标;一秒用力呼气容积(FEV_(1))、用力肺活量(FVC)、一秒率(FEV_(1)/FVC)及肺活量(VC)肺功能指标;不良反应情况。结果观察组治疗有效率和对照组相比更高,差异具有统计学意义(P<0.05)。治疗前,两组咳嗽、喘息、咳痰和肺呼吸音症状评分差异无统计学意义(P>0.05);治疗后,观察组咳嗽、喘息、咳痰和肺呼吸音症状评分和对照组相比更低,差异具有统计学意义(P<0.05)。治疗前,两组PaO_(2)及PaCO_(2)水平差异无统计学意义(P>0.05);治疗后,观察组PaO_(2)水平和对照组相比更高,PaCO_(2)水平和对照组相比更低,差异均有统计学意义(P<0.05)。治疗前,两组FEV_(1)、FVC、FEV_(1)/FVC及VC水平差异无统计学意义(P>0.05);治疗后,观察组FEV_(1)、FVC、FEV_(1)/FVC及VC水平和对照组相比更高,差异具有统计学意义(P<0.05)。两组不良反应差异无统计学意义(P>0.05)。结论补中益气汤合二陈汤加针刺对COPD患者疗效理想,能改善其临床症状及血气分析指标,增强其肺功能,值得采用。Objective To analyze the clinical effectiveness of Buzhongyiqi decoction,Erchen decoction and acupuncture in chronic obstructive pulmonary disease(COPD)patients.Methods A total of 65 COPD patients treated from August 2019 to August 2022 in Zhengzhou Central Hospital Rehabilitation Branch were selected.According to random number table,patients were assigned to control group(conventional Western medicine therapy)of 33 cases and observation group(using Buzhongyiqi decoction,Erchen decoction and acupuncture on the basis of the control group)of 32 cases.Compare the therapeutic effects of the two groups;Symptom score;Score of symptoms such as cough,wheezing,expectoration,and lung breathing sounds before and after treatment;Blood gas analysis indicators such as partial pressure of blood oxygen(PaO_(2))and partial pressure of carbon dioxide(PaCO_(2));Lung function indicators such as forced expiratory volume in one second(FEV_(1)),forced vital capacity(FVC),FEV_(1)/FVC,and vital capacity(VC);adverse reactions.Results The effective treatment rates in the observation group were higher than control group,and the difference was statistically significant(P<0.05);before treatment,there were no significant between-group differences about the clinical symptom scores of cough,wheezing,expectoration and respiratory sound(P>0.05);after treatment,the clinical symptom scores of cough,wheezing,expectoration and respiratory sound in the observation group were lower than control group and the difference were statistically significant(P<0.05);before treatment,PaO_(2)and PaCO_(2)values between groups were not significantly different(P>0.05);after treatment,PaO_(2)values in the observation group were higher than control group,PaCO_(2)values in the observation group were lower than control group,and the difference were statistically significant(P<0.05);before treatment,FEV_(1),FVC,FEV_(1)/FVC and VC values between groups were not significantly different(P>0.05);after treatment,FEV_(1),FVC,FEV_(1)/FVC and VC values in the observation group we

关 键 词：补中益气汤 二陈汤 慢阻肺 血气分析 肺功能 不良反应 

分 类 号：R563[医药卫生—呼吸系统]